CEMI Chembio Diagnostics upside potentialChembio Diagnostics' analysts are forecasting revenues of US$54m in 2021, a substantial 56% improvement in sales compared to the last year.
CEMI follows its bigger more profitable brother CODX in price action.
Depending on the future development of the global pandemic, those stocks could grow rapidly.
On 12/3/2020 Craig Hallum brokerage Upgraded the stock from Hold to Buy from $5.00 to $10.00 price target.
Because of the offering, I've lowered my price target to 5.5usd.
I`m looking forward to read your opinion about CEMI.
Chembiodiagnostics
CEMI Chembio Diagnostics Earnings August 5thTomorrow Chembio Diagnostics CEMI will Report Second Quarter 2021 Financial Results.
Things to consider:
$28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil
$4 million purchase order from the Partnership for Supply Chain Management (PFSCM), for the purchase of HIV 1/2 STAT-PAK Assay for shipment to Ethiopia
those are just some big orders from July, Q3, for which we could se a business update tomorrow at the earnings call.
Craig Hallum has a $10.00 price target for it.
